Company Number: 13820409

Analysis Date: 2025-07-29 15:51 UTC

Financial Health Assessment for RAS Scaffolding Ltd (Year Ending 31 December 2023)

---

1. Financial Health Score: B

Explanation:
RAS Scaffolding Ltd displays a solid and improving financial position with increasing net assets and net current assets, healthy working capital, and no signs of distress or overdue filings. However, the company's low cash reserves relative to debtors and modest liquidity cushions suggest some room for improvement in cash flow management.

---

2. Key Vital Signs

Metric	2023 Value	Interpretation
Current Assets	£37,227	Adequate short-term resources to cover liabilities
Cash at Bank	£1,997	Low immediate liquidity; cash flow may be tight
Debtors	£35,230	High receivables indicate sales on credit; risk of delay in cash inflows
Current Liabilities	£9,813	Short-term obligations are modest
Net Current Assets (Working Capital)	£27,414	Positive working capital indicates healthy short-term financial stability
Net Assets (Equity)	£68,326	Positive net worth reflects retained earnings and asset growth
Fixed Assets (Net Book Value)	£40,912	Investment in plant and machinery, supporting operational capacity
Shareholders’ Funds	£68,326	Equity backing is strong for a small company
Number of Employees	3	Small, focused team consistent with Micro/Small company

Interpretation of Vital Signs:

• Healthy working capital indicates the company can cover its short-term liabilities comfortably, a good sign akin to a stable pulse rate.
• Low cash reserves are a symptom of potential cash flow tightness, particularly given the high debtor balance. This can cause liquidity "breathlessness" despite overall asset strength.
• Increasing net assets year on year show the company is building financial strength, akin to gaining muscle tone.
• No overdue filings or legal issues suggest good management and regulatory compliance "immune system."

---

3. Diagnosis: Overall Financial Condition

RAS Scaffolding Ltd is financially stable with a positive net asset position and growing equity, indicating profitability and prudent management of resources since incorporation in late 2021. The company's balance sheet shows a strong working capital position, meaning it has sufficient short-term assets to meet liabilities, an essential marker of financial health.

However, the company has a high level of debtors relative to cash on hand, which is a symptom worth monitoring. This suggests possible delays in collecting payments from customers, which could strain liquidity if prolonged. The relatively low cash reserves compared to current liabilities could create a risk of cash flow crunch, especially if unexpected expenses arise.

The investment in tangible fixed assets (plant, machinery, motor vehicles) supports ongoing operational capability and growth potential, but also requires ongoing maintenance of cash flow to service any associated costs or depreciation.

In medical terms, the company is "fit and functioning well," but shows a mild "circulatory issue" in cash flow management that should be addressed to avoid future strain.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

1. Enhance Cash Flow Management:

   • Implement stricter credit control to reduce debtor days and accelerate cash collections.
   • Negotiate payment terms with customers to improve liquidity timing.
   • Maintain a cash buffer to handle unforeseen expenses and avoid liquidity "dips."

2. Monitor Debtor Aging:

   • Regularly review the aging profile of debtors to identify slow-paying customers early and take corrective actions.

3. Review Cost Structures:

   • Analyze operational expenses and overheads to identify savings opportunities that improve net margins and cash flows.

4. Plan Capital Expenditure Prudently:

   • While fixed asset investment is healthy, ensure that future purchases are aligned with cash flow capabilities to avoid overextension.

5. Build Financial Resilience:

   • Consider building a modest contingency reserve to safeguard against market fluctuations or economic downturns.

6. Maintain Compliance and Transparency:

   • Continue timely filing of accounts and confirmations to sustain regulatory "immune system" strength and stakeholder confidence.

---